New Delhi [India], December 7 (ANI): Bharat Biotech on Monday applied for emergency use authorisation for its indigenously developed COVID-19 vaccine 'Covaxin' to Drugs Controller General of India (DCGI), officials said.
New Delhi [India], December 6 (ANI): Haryana Home Minister Anil Vij who tested positive for Covid-19 on December 5 and is hospitalized said on Sunday that he was told by doctors before being administered the first dose during the phase 3 trial of Bharat Biotech's coronavirus vaccine Covaxin
New Delhi [India], December 5 (ANI): After Haryana Home Minister Anil Vij tested positive for the COVID-19 despite taking a shot of Bharat Biotech's vaccine candidate around two weeks ago, the company clarified on Saturday that its efficacy can only be determined 14 days after the second
New Delhi [India], December 5 (ANI): Haryana Home Minister Anil Vij, who received the first dose of Bharat Biotech's COVID-19 vaccine candidate, Covaxin, during its Phase-III trial in the state two weeks ago, on Saturday said that he has tested positive for the virus.
Kolkata (West Bengal) [India], December 2 (ANI): West Bengal Governor Jagdeep Dhankhar inaugurated the phase III regulatory trial of Bharat Biotech's coronavirus vaccine candidate Covaxin in Kolkata on Wednesday.
Amaravati (Andhra Pradesh) [India], November 28 (ANI): Prime Minister Narendra Modi's visit to Genome Valley in Hyderabad will serve as a strong motivation for Bharat Biotech to make the Coronavirus vaccine Covaxin, said Telugu Desam Party's (TDP) national president and former Chief Minis
Hyderabad (Telangana) [India], November 28 (ANI): Prime Minister Narendra Modi on Saturday visited the manufacturing facility of Bharat Biotech International Limited (BBIL) in Telangana to review the development of its 'Covaxin' Covid-19 vaccine candidate.
Ahmedabad (Gujarat) [India], November 27 (ANI): The Phase-3 trial of COVID-19 vaccine candidate Covaxin begun with five volunteers at Sola Civil Hospital in Ahmedabad on Thursday.
Dhaka [Bangladesh], November 25 (ANI): Bangladesh is expected to get 68 million COVID-19 vaccine doses from the Gavi, the Vaccine Alliance, under the global arrangement called Covax facility within 2021.
Riyadh [Saudi Arabia], November 22 (ANI/Sputnik): The G20 countries have vowed to make efforts to ensure universal access to COVID-19 vaccines, therapeutics and diagnostics, a final statement adopted on Sunday after a two-day G20 summit said.
Bhubaneswar (Odisha) [India], November 21 (ANI): In phase 3, COVAXIN's effectiveness to prevent the disease (coronavirus) will be checked, said Dr. E Venkata Rao, Principal investigator of COVAXIN trial at Institute of Medical Sciences and SUM Hospital, Bhubaneswar, while adding that out
Chandigarh [India], November 20 (ANI): All government and private schools in Haryana will remain closed till November 30 in view of COVID-19 situation, the state government said on Friday.